期刊文献+

益肾胶囊对糖尿病肾病大鼠肾组织炎症因子NF-κB的影响 被引量:10

Effect of Yishen Capsule on Expression of NF-κB in Renal Tissue of Rat with Diabetic Nephropathy
下载PDF
导出
摘要 目的:观察益肾胶囊对糖尿病肾病(DN)大鼠肾组织核转录因子-κB(nuclear factor-κB,NF-κB)表达的影响。方法:将40只健康雄性Wistar大鼠随机分为:正常对照组(对照组)、DN模型组(模型组)、氯沙坦组、益肾胶囊组,每组10只。利用链脲佐菌素(STZ)诱导右肾切除的大鼠制备DN模型。氯沙坦组灌胃氯沙坦钾20mg·kg-1.d-1,益肾胶囊组灌胃益肾胶囊625mg·kg-1.d-1,对照组及模型组每日给予等量的蒸镏水灌胃,实验周期为12周。实验过程中观察大鼠24h尿蛋白定量、血肌酐(Scr)、尿素氮(BUN)变化,光镜下观察肾脏病理变化,采用免疫荧光法检测各组大鼠肾组织NF-κB的表达。结果:12周末,DN模型组大鼠的24h尿蛋白定量、Scr、BUN均高于正常对照组(P<0.05),肾组织中NF-κB表达水平明显高于正常对照组(P<0.05);益肾胶囊治疗组大鼠24h尿蛋白定量、Scr、BUN均低于模型组(P<0.05),肾组织NF-κB表达水平明显低于DN模型组(P<0.05)。结论:益肾胶囊可能通过下调DN大鼠肾脏组织NF-κB的表达,延缓DN的进展。 Objective:To observe the yishen capsule of diabetic nephropathy (DN) of renal inflammatory factor NF-κB (nuclear factor-κB) expression,DN for the yishen capsule provides theoretical and experimental basis.Methods:40 healthy male Wistar rats were randomly divided into:normal control group (control group),DN model group (model group),losartan group,yishen capsule group,10 in each group.Using streptozotocin (STZ) induced rat right yishen removed preparation DN model.Losartan losartan potassium administered daily 20 mg·kg-1·d-1,yishen capsule administered daily yishen capsule 625 mg·kg-1·d-1,the control group and model group every day for the same amount of distilled pour stomach,experimental period of 12 weeks.Experiment rats 24 h urinary protein,serum creatinine (Scr),blood urea nitrogen (BUN) changes in light of renal pathological changes were observed using immunofluorescence in renal tissue NF-κB expression.Results:12 weekends,DN model group,24 h urinary protein,Scr,BUN were higher than the control group (P0.05),renal tissue expression of NF-κB was significantly higher than the normal control group (P0.05);yishen capsule treated rats 24 h urinary protein,Scr,BUN were lower than model group (P0.05),renal tissue expression of NF-κB levels were significantly lower than the DN model group (P0.05).Conclusion:yishen capsule in rats may be attributed to yishen DN NF-κB expression,delaying the progress of DN.
出处 《中国中西医结合肾病杂志》 2010年第7期577-580,共4页 Chinese Journal of Integrated Traditional and Western Nephrology
关键词 益肾胶囊 糖尿病肾病 核转录因子-ΚB Yishen capsule Diabetic nephropathy(DN) Nuclear factor-κB(NF-κB)
  • 相关文献

参考文献13

  • 1Devaraj S,Dasu MR,Jialal I.Diabetes is a proinflammatory state:a translational perspective.Expert Rev Endocrinol Metab,2010,5(1):19-28.
  • 2Kurien BT.Inhibition of p300 and nuclear factor-kappaB by curcumin and its role in diabetic nephropathy.Nutrition,2009,25(9):973-974.
  • 3Ndisang JF,Jadhav A.Heine oxygenase system enhances insulin sensitivity and glucose metabolism in streptozotocin-induced diabetes.Am J Physiol Endocrinol Metab,2009,296(4):E829-E841.
  • 4Pepper C,Hewamana S,Brennan P,et al.NF-kappaB as a prognostic marker and therapeutic target in chronic lymphocytic leukemia.Future Oncol,2009,5(7):1027-1037.
  • 5Papa S,Bubici C,Zazzeroni F,et al.Mechanisms of liver disease:cross-talk between the NF-kappaB and JNK pathways.Biol Chin,2009,390(10):965-976.
  • 6Chariot A.The NF-kappaB-independent functions of IKK subunits in immunity and cancer.Trends Cell Biol,2009,19(8):404-413.
  • 7Mezzano S,Aros C,Droguett A,et al.NF-kappaB activation and overexpression of regulated genes in human diabetic nephropathy.Nephrol Dial Transplant,2004,19(10):2505-2512.
  • 8Ha H,Yu MR,Choi YJ,et al.Role of high glucose-induced nuclear factor-kappaB activation in monocyte chemoattractant protein-1 expression by mesangial cells.J Am Soc Nephrol,2002,13(4):894-902.
  • 9Mohamed MR,McFadden G.NF-kB inhibitors:strategies from poxviruses.Cell Cycle,2009,8(19):3125-3132.
  • 10Bamborough P,Callahan JF.Progress towards the development of anti-inflammatory inhibitors of IKKbeta.Curt Top Med Chem,2009,9(7):623-639.

二级参考文献44

  • 1白云静,孟庆刚.糖尿病肾病中医辨证现代化研究述评[J].中国中西医结合肾病杂志,2004,5(12):742-744. 被引量:8
  • 2方敬爱,邓安国,刘建社.益肾胶囊治疗早期糖尿病肾病的临床研究[J].中国中西医结合肾病杂志,2005,6(8):457-459. 被引量:15
  • 3李永强,黄海长,白秀珍,蒋洪.足细胞与糖尿病肾病[J].中国中西医结合肾病杂志,2005,6(12):739-741. 被引量:6
  • 4王树立 李永德 等.山楂、黄芪及刺五加对豚鼠胆固醇代谢的影响[J].中西医结合杂志,1987,7(8):483-484.
  • 5Robkin R. Diabetic nephropathy. Clin Cornerstone, 2003,5(2):1-11.
  • 6Bianchi S, Bigazzi R,Campese VM. Microalbuminuria in essential hypertension. Significance, pathophysiology, and the therapeutic implications. Am J Kidney Dis, 1999,34(6): 973- 995.
  • 7Pedrinelli R, Giampietro O, Carmassi F, et al. Microalbuminuria and endothelial dysfunction in essential hypertension.Lancet, 1994,344(8914): 14 - 18.
  • 8王海燕 王梅.慢性肾脏病及透析的临床实践指南Ⅱ[M].北京:人民卫生出版社,2005,6.133-166.
  • 9Nelesen Fs,Rossing P,Gall MA ,et al. Impacct of lisinopril and atenol on kidney function in hypertensive NIDDM subjects with diabetic nephropathy. Diabetes, 1994,43 (9): 1108 - 1113.
  • 10Leppluoto J, Ruskoaho H. Endothelin peptides biological activities, cellular signalling and clinical significance. Ann Med, 1992,24(3): 153 - 161.

共引文献36

同被引文献201

引证文献10

二级引证文献63

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部